Immupharma PLC Holding(s) in Company (1863A)
March 22 2017 - 04:51AM
UK Regulatory
TIDMIMM
RNS Number : 1863A
Immupharma PLC
22 March 2017
22 MARCH 2017
NOTIFICATION OF MAJOR INTEREST BY ALTO INVEST
ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, announces that
it has received notification by Alto Invest ("Alto") confirming its
holding in ImmuPharma of 5,802,317 million Ordinary Shares in the
capital of the Company, representing 4.38% of ImmuPharma's total
voting rights figure of 132,522,985 Ordinary Shares.
Commenting, Tim McCarthy, Chairman of ImmuPharma, said: "We are
delighted to be able to disclose Alto's increased holding in
ImmuPharma as a further key major institutional investor which
participated in our recent successful GBP4.1 million fundraising
demonstrating its continued support for ImmuPharma."
Ends
For further information please
contact:
+ 44 (0) 20
ImmuPharma plc (www.immupharma.org) 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor
Relations + 44 (0) 7721
Twitter: @immupharma 413496
Northland Capital Partners Limited
(NOMAD & Broker)
Patrick Claridge, David Hignell,
Michael Mackintosh, Corporate
Finance +44 (0)20 3861
Rob Rees, Corporate Broking 6625
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLVLLBLDXFZBBK
(END) Dow Jones Newswires
March 22, 2017 04:51 ET (08:51 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2023 to Mar 2024